Logo-bi
Bioimpacts. 2024;14(1): 27758. doi: 10.34172/bi.2023.27758
PMID: 38327636        PMCID: PMC10844590

Original Article

Inhibitory effect of miR342 on the progression of triple-negative breast cancer cells in vitro and in the mice model

Zahra Alidoost 1 ORCID, Farnoosh Attari 1 * ORCID, Fatemeh Saadatpour 2, Ehsan Arefian 2

Cited by CrossRef: 0


1- Song Y, Zhang P, Bhushan S, Wu X, Zheng H, Yang Y. The Critical Role of Inhibitor of Differentiation 4 in Breast Cancer: From Mammary Gland Development to Tumor Progression. Cancer Medicine. 2025;14(7) [Crossref]

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMedPubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science IndicatorsEmbase; EBSCOhost; CAS: DOAJSHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons